Evidence map›Paper›PMID 41980951›Full record

ArticleNature communications2026

Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer's disease model.

Yiannis Poulot-Becq-Giraudon, Océane Guillemaud, Elisa Degl'Innocenti, Vivien Letenneur, Karouna Bascarane, Tony Barbay, Mie Møller Clausen, Céline Derbois, Martine Guillermier, Ludmila Juricek and 19 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Yiannis Poulot-Becq-GiraudonUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France.ORCID 0000-0003-3871-9259
Océane Guillemaud *Université Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Elisa Degl'Innocenti *Université Paris-Saclay, CNRS, NeuroPSI, Saclay, France.ORCID 0000-0002-3819-0116
Vivien Letenneur *Université Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Karouna Bascarane *Université Paris-Saclay, CNRS, NeuroPSI, Saclay, France.
Tony Barbay *Aix Marseille Université, CNRS, Institut de Neurosciences de la Timone (INT), Marseille, France.ORCID 0009-0004-1872-993X
Mie Møller Clausen *Université Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.ORCID 0009-0001-4241-5760
Céline Derbois *Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.
Martine Guillermier *Université Paris-Saclay, CNRS, NeuroPSI, Saclay, France.
Ludmila JuricekUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Miriam Riquelme-PerezUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.ORCID 0000-0002-9204-3088
Tom LakomyUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France.ORCID 0009-0009-0508-2467
Lucile BenhaimUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France.
Noëlle DufourUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Pauline GipchteinUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Fanny PetitUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Léa SironUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France.
Gwennaëlle AuréganUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Nathalie DechampsUniversité Paris Cité, Inserm, CEA, Stabilité Génétique Cellules Souches et Radiations, iRCM/IBFJ, Fontenay-aux-Roses, France.
Marie-Claude GaillardUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.
Alexis-Pierre BemelmansUniversité Paris-Saclay, CEA, CNRS, MIRCen, Laboratoire des Maladies Neurodégénératives, Fontenay-aux-Roses, France.ORCID 0000-0001-7605-5225
Rémi BosAix Marseille Université, CNRS, Institut de Neurosciences de la Timone (INT), Marseille, France.ORCID 0000-0003-2639-3271
Maria-Angeles Carrillo-de SauvageUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France.ORCID 0000-0002-3312-5956
Giampaolo MiliorCollège de France, CNRS, INSERM, PSL-NEURO, Université PSL, Paris, France.ORCID 0009-0000-4318-6923
Nathalie RouachCollège de France, CNRS, INSERM, PSL-NEURO, Université PSL, Paris, France.ORCID 0000-0002-5574-888X
Solène Brohard *Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.ORCID 0000-0002-0209-5467
Kevin Muret *Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.ORCID 0000-0003-3988-7772
Eric BonnetUniversité Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.ORCID 0000-0002-8468-2867
Carole EscartinUniversité Paris-Saclay, CNRS, NeuroPSI, Saclay, France. carole.escartin@cnrs.fr.ORCID 0000-0003-3613-4118

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-10-IDEX-0001Agence Nationale de la Recherche (French National Research Agency) ANR-16-TERC-0016-01 and ANR21-CE17-0047-02Association France Alzheimer (French Alzheimer's Association) 6173Fondation pour la Recherche Médicale (Foundation for Medical Research in France) EQU202303016285
6 · The paper itself

Abstract

Astrocytes are key partners for neurons and can impact diseases such as Alzheimer's disease (AD), as they exhibit multiple reactive changes. Recent single cell/nucleus genomics analyses evidence astrocyte subpopulations coexisting in normal and AD brains. However, the signaling cascades controlling them, their functional characteristics and roles in AD are still unknown. Here, thanks to astrocyte-specific reporters for STAT3 and NF-kB signaling pathways, two regulators of astrocyte reactivity, we report the presence of three astrocyte subpopulations defined by their signaling activity, in the prefrontal cortex of male APP/PS1dE9 mice. These subpopulations are not triggered by amyloid deposition and are also observed in wild-type mice. They show distinct morphologies, molecular signatures and functional profiles. While NF-kB+ astrocytes have larger territories and higher lysosomal activity, STAT3+ astrocytes display enhanced hemichannel activity. Specific inhibition of these subpopulations reduces amyloid plaque size and impacts anxiety, social preference and social memory in AD but not wild-type mice. Our results show how innate signaling shapes astrocyte subpopulations in the mouse cortex, with distinct functions in health and disease.

Indexed as

Alzheimer DiseaseAstrocytesSignal TransductionAmyloid beta-Protein PrecursorAnimalsCerebral CortexDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLMice, TransgenicNF-kappa BPlaque, AmyloidPrefrontal CortexPresenilin-1Amyloid beta-Protein PrecursorNF-kappa BPresenilin-1Stat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID41980951
PMCPMC13153161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.